Tag Archives: Craig Bijou

Cantor Fitzgerald Thinks Ra Medical Systems Inc’s Stock is Going to Recover

Cantor Fitzgerald analyst Craig Bijou reiterated a Buy rating on Ra Medical Systems Inc (RMED – Research Report) yesterday and set a price target of $11. The company’s shares closed yesterday at $3.96, close to its 52-week low of $3.76.

Cantor Fitzgerald Sticks to Their Buy Rating for Globus Medical (GMED)

In a report released today, Craig Bijou from Cantor Fitzgerald reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of $60. The company’s shares opened today at $49. Bijou commented: “We reiterate our Overweight

Integra Lifesciences (IART) Gets a Hold Rating from Cantor Fitzgerald

In a report released today, Craig Bijou from Cantor Fitzgerald maintained a Hold rating on Integra Lifesciences (IART – Research Report), with a price target of $50. The company’s shares closed yesterday at $51.93. Bijou commented: “We maintain our Neutral

Cantor Fitzgerald Sticks to Its Hold Rating for NuVasive (NUVA)

Cantor Fitzgerald analyst Craig Bijou maintained a Hold rating on NuVasive (NUVA – Research Report) yesterday and set a price target of $50. The company’s shares closed on Friday at $49.55. Bijou said: “We maintain our Neutral rating and 12-month

Intuitive Surgical (ISRG): New Buy Recommendation for This Healthcare Giant

In a report released today, Craig Bijou from Cantor Fitzgerald reiterated a Buy rating on Intuitive Surgical (ISRG – Research Report), with a price target of $620. The company’s shares closed yesterday at $536.12. Bijou said: “: We reiterate our

Cantor Fitzgerald Thinks AxoGen’s Stock is Going to Recover

Cantor Fitzgerald analyst Craig Bijou reiterated a Buy rating on AxoGen (AXGN – Research Report) today and set a price target of $26. The company’s shares closed on Friday at $16.03, close to its 52-week low of $14.13. Bijou observed: